Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27294721 | 0.86 | TSHR (0.38) | TP53TSHRSLC7A5HCAR2 | |
| SCHEMBL3073110 | 0.79 | ALDH1A1 (0.38) | TP53TSHRCYP2D6CYP2C19TDP1 | |
| SCHEMBL11588540 | 0.79 | TP53 (0.40) | TP53TSHRSLC7A5CYP2C19TDP1 | |
| Bicarbonate SCHEMBL28488934 | 0.76 | TSHR (0.42) | TP53TSHRSLC7A5HCAR2CYP2D6 | |
| SCHEMBL989972 | 0.75 | — | — | |
| SCHEMBL1196880 | 0.75 | TP53 (0.42) | TP53TSHRSLC7A5HCAR2GABRR1 | |
| SCHEMBL4332630 | 0.75 | — | — | |
| SCHEMBL28632671 | 0.75 | — | — | |
| SCHEMBL607461 | 0.75 | TP53 (0.42) | TP53TSHRSLC7A5HCAR2GABRR1 | |
| Lactic Acid SCHEMBL27395815 | 0.75 | TP53 (0.69) | TP53TSHRSLC7A5HCAR2RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-12612394-B2 | Herbicidal malonamides | BASF SE (DE) | 2026-04-28 | — | — | US | disclosed |
| US-20230150989-A1 | HERBICIDAL MALONAMIDES | BASF SE (DE) | 2023-05-18 | — | — | US | disclosed |
| EP-4110763-A1 | HERBICIDAL MALONAMIDES | BASF SE (DE) | 2023-01-04 | — | — | EP | disclosed |
| CN-115190875-A | Herbicidal malonamides | 巴斯夫欧洲公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-110366549-A | Compound as interleukin-1 activity inhibitor | 基因泰克公司 | 2019-10-22 | — | — | CN | disclosed |
| EP-2627655-B1 | FUSED 3-OXO-PYRAZOLO[4,3-c]PYRIDINE COMPOUNDS AS GABAA MODULATORS | DART NEUROSCIENCE CAYMAN LTD (KY) | 2015-09-16 | — | — | EP | disclosed |
| US-9012470-B2 | Therapeutic 5,6,5-tricyclic analogs | DART NEUROSCIENCE (CAYMAN) LTD. (KY) | 2015-04-21 | — | — | US | disclosed |
| EP-2627655-A2 | THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS | Dart NeuroScience (Cayman) Ltd (KY) | 2013-08-21 | — | — | EP | disclosed |
| US-20120095016-A1 | THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS | HELICON THERAPEUTICS, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| WO-2012051213-A2 | THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS | HELICON THERAPEUTICS, INC. (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20060054290-A1 | Novel catalytic activities of oxidoreductases for oxidation and or bleaching | CALL HANS-PETER | 2006-03-16 | — | — | US | disclosed |
| EP-1483442-A2 | NOVEL CATALYTIC ACTIVITIES OF OXIDOREDUCTASES FOR OXIDATION AND/OR BLEACHING | Call, Krimhild (DE) | 2004-12-08 | — | — | EP | disclosed |
| EP-1436371-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | Call, Krimhild (DE) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003061550-A2 | NOVEL CATALYTIC ACTIVITIES OF OXIDOREDUCTASES FOR OXIDATION AND/OR BLEACHING | CALL, KRIMHILD (DE) | 2003-07-31 | — | — | WO | disclosed |
| WO-2002099023-A2 | ENZYMATIC SYSTEMS FOR GENERATING ACTIVE OXYGEN SPECIES FOR REACTING WITH OTHER PRECURSORS TO OBTAIN OXIDATION AND/OR BLEACHING | CALL, KRIMHILD (DE) | 2002-12-12 | — | — | WO | disclosed |
| EP-1012376-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | Blume, Hildegard (DE) | 2000-06-28 | — | — | EP | disclosed |
| WO-1998059108-A2 | OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS | BLUME, HILDEGARD (DE) | 1998-12-30 | — | — | WO | disclosed |
| EP-0714896-A1 | INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF MIGRAINE, COMPOSITION AND UTILIZATION | VITA-INVEST, S.A. (ES) | 1996-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612394-B2 | Herbicidal malonamides | CBR3, DDT, HACL2 | TP53 4695/4885TSHR 2236/4885SLC7A5 2281/4885 |
| US-20230150989-A1 | HERBICIDAL MALONAMIDES | DDT, DHRS9, CA9 | TP53 4576/4885TSHR 1855/4885SLC7A5 1693/4885 |
| US-20120095016-A1 | THERAPEUTIC 5,6,5-TRICYCLIC ANALOGS | GABRA5, GABRA6, GABRB1 | TP53 4874/4885TSHR 451/4885SLC7A5 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.